Eiger Biopharmaceuticals

Eiger BioPharmaceuticals is a biopharmaceutical company. The company has five product candidate pipeline programs: Lonafarnib (LNF) in Hepatitis Delta Virus (HDV), which is an orally bioavailable, farnesylation inhibitor for HDV infection; Peginterferon Lambda in HDV, which is a type III interferon that stimulates immune responses that are key for the development of host protection during viral infections; LNF in Progeria and Progeroid Laminopathies (PL), in which it is developing LNF for treatment of Progeria and PL; Avexitide in Post-Bariatric Hypoglycemia (PBH), in which it is developing as a treatment for PBH; and Avexitide in Congenital Hyperinsulinism (CHI), which is a treatment for CHI.
  • TickerEIGR
  • ISINUS28249U1051
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States
Liana Moussatos ... (+3)
  • Liana Moussatos
  • Shveta Dighe
  • Andreas Argyrides
Liana Moussatos ... (+3)
  • Liana Moussatos
  • Shveta Dighe
  • Andreas Argyrides
Liana Moussatos ... (+3)
  • Liana Moussatos
  • Shveta Dighe
  • Andreas Argyrides
Liana Moussatos ... (+3)
  • Liana Moussatos
  • Shveta Dighe
  • Andreas Argyrides
Liana Moussatos ... (+3)
  • Liana Moussatos
  • Shveta Dighe
  • Andreas Argyrides
Liana Moussatos ... (+3)
  • Liana Moussatos
  • Shveta Dighe
  • Andreas Argyrides
Liana Moussatos ... (+3)
  • Liana Moussatos
  • Shveta Dighe
  • Andreas Argyrides
Liana Moussatos ... (+3)
  • Liana Moussatos
  • Shveta Dighe
  • Andreas Argyrides
Liana Moussatos ... (+3)
  • Liana Moussatos
  • Shveta Dighe
  • Andreas Argyrides
Liana Moussatos ... (+3)
  • Liana Moussatos
  • Shveta Dighe
  • Andreas Argyrides
Liana Moussatos ... (+3)
  • Liana Moussatos
  • Shveta Dighe
  • Andreas Argyrides
Liana Moussatos ... (+3)
  • Liana Moussatos
  • Shveta Dighe
  • Andreas Argyrides
Liana Moussatos ... (+3)
  • Liana Moussatos
  • Shveta Dighe
  • Andreas Argyrides
Liana Moussatos ... (+3)
  • Liana Moussatos
  • Shveta Dighe
  • Andreas Argyrides
Liana Moussatos ... (+3)
  • Liana Moussatos
  • Shveta Dighe
  • Andreas Argyrides
Liana Moussatos ... (+3)
  • Liana Moussatos
  • Shveta Dighe
  • Andreas Argyrides
Liana Moussatos ... (+3)
  • Liana Moussatos
  • Shveta Dighe
  • Andreas Argyrides
Liana Moussatos ... (+3)
  • Liana Moussatos
  • Shveta Dighe
  • Andreas Argyrides
Liana Moussatos ... (+3)
  • Liana Moussatos
  • Shveta Dighe
  • Andreas Argyrides
Liana Moussatos ... (+3)
  • Liana Moussatos
  • Shveta Dighe
  • Andreas Argyrides

ResearchPool Subscriptions

Get the most out of your insights

Get in touch